tiprankstipranks
Trending News
More News >
Universe Pharmaceuticals (UPC)
NASDAQ:UPC
US Market
Advertisement

Universe Pharmaceuticals (UPC) Income Statement

Compare
194 Followers

Universe Pharmaceuticals Income Statement

Last quarter (Q2 2025), Universe Pharmaceuticals's total revenue was $9.15M, a decrease of -50.44% from the same quarter last year. In Q2, Universe Pharmaceuticals's net income was $-3.28M. See Universe Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Sep 24Sep 23Sep 22Sep 21Sep 20
Total Revenue
$ 23.02M$ 32.31M$ 40.14M$ 47.98M$ 30.70M
Gross Profit
$ 6.07M$ 10.32M$ 21.89M$ 25.33M$ 14.09M
Operating Expenses
$ 14.09M$ 13.84M$ 28.91M$ 11.74M$ 3.74M
Depreciation and Amortization
$ 485.73K$ 508.79K$ 533.95K$ 446.88K$ 410.08K
EBITDA
$ -7.36M$ -3.22M$ -6.40M$ 14.20M$ 10.61M
Operating Income
$ -8.02M$ -3.53M$ -7.02M$ 13.59M$ 10.25M
Other Income/Expenses
$ -100.75K$ -322.80K$ -545.35K$ 88.34K$ -151.29K
Pretax Income
$ -8.12M$ -3.85M$ -7.98M$ 13.68M$ 10.10M
Net Income
$ -8.73M$ -6.16M$ -8.74M$ 11.32M$ 7.56M
Per Share Metrics
Basic EPS
$ -1.44K$ -1.04K$ -1.48K$ 2.15K$ 1.30K
Diluted EPS
$ -1.44K$ -1.04K$ -1.48K$ 2.15K$ 1.30K
Weighted Average Shares Outstanding
6.08K 5.92K 5.92K 5.27K 5.83K
Weighted Average Shares Outstanding (Diluted)
6.08K 5.92K 5.92K 5.27K 5.83K
Currency in USD

Universe Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis